PharmaShots | Incisive News in 3 Shots

Subscribe Now

MGTA-117

Magenta Therapeutics Pauses the P-I/II Study in AML Patients

Magenta Therapeutics Pauses the P-I/II Study in AML Patients

January 27, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us